Reagents and consumables for the walter reed national medical center lab
Ended Awarded Last action
- Contract number
- HT001418F0129
- Awardee
-
Biofire Diagnostics LLC UEI TBBNREFT3LD3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $500,000
Award facts
- Contract value 100% obligated
- $500,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
About this award
This contract was awarded by the Defense Health Agency to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide reagents and consumables for the Walter Reed National Military Medical Center laboratory. The contract is a Blanket Purchase Agreement (BPA) call against Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in vitro diagnostics, reagents, and tests. The potential value of the contract is $500,000, and it has a completion date of February 28, 2019. The contract is for firm fixed-price reagents and consumables, with no set-aside designation. Biofire Diagnostics is a leader in syndromic infectious disease testing, and has received numerous federal contract awards to provide a variety of goods and services related to infectious disease testing, including to the Department of Veterans Affairs, Department of Health and Human Services Indian Health Service, and Department of State.
Quick answers
Who was awarded contract HT001418F0129?
HT001418F0129 was awarded to Biofire Diagnostics LLC by Defense Health Agency (Department of Defense) on March 1, 2018.
How much is contract HT001418F0129 worth?
The government has obligated $500,000 on HT001418F0129.
Is contract HT001418F0129 an order under another contract?
Yes. HT001418F0129 is a BPA call under V797D30085-HT001417A0045, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract HT001418F0129 competed?
The extent of competition for HT001418F0129 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award